APO Research
Talk to an analyst

APO RESEARCH · REPORT

Streptococcus Pneumoniae Polysaccharide Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Outlook and Growth Opportunities 2026

30 December 2025192 pages

Choose your research edition.

Industry ResearchStreptococcus Pneumoniae Polysaccharide Vaccine Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Streptococcus Pneumoniae Polysaccharide Vaccine Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Streptococcus Pneumoniae Polysaccharide Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Streptococcus Pneumoniae Polysaccharide Vaccine Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Streptococcus Pneumoniae Polysaccharide Vaccine Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Streptococcus Pneumoniae Polysaccharide Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Streptococcus Pneumoniae Polysaccharide Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Streptococcus Pneumoniae Polysaccharide Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Streptococcus Pneumoniae Polysaccharide Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Streptococcus Pneumoniae Polysaccharide Vaccine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Streptococcus Pneumoniae Polysaccharide Vaccine market include Yuxi Watson Biotechnology Co., Ltd, Merck & Co.,Inc, Pfizer Inc, Chengdu Institute of Biological Products Co., Ltd, Beijing Minhai Biotechnology Co., Ltd, Beijing Kexing Biological Products Co., Ltd, Serum Institute of India Pvt. Ltd, Sanofi Pasteur and Glaxosmithkline Plc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Streptococcus Pneumoniae Polysaccharide Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Streptococcus Pneumoniae Polysaccharide Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Streptococcus Pneumoniae Polysaccharide Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Streptococcus Pneumoniae Polysaccharide Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Streptococcus Pneumoniae Polysaccharide Vaccine Segment by Company

Yuxi Watson Biotechnology Co., Ltd

Merck & Co.,Inc

Pfizer Inc

Chengdu Institute of Biological Products Co., Ltd

Beijing Minhai Biotechnology Co., Ltd

Beijing Kexing Biological Products Co., Ltd

Serum Institute of India Pvt. Ltd

Sanofi Pasteur

Glaxosmithkline Plc

China National Biotec Group

Astellas Pharma Inc

Streptococcus Pneumoniae Polysaccharide Vaccine Segment by Type

Single Dose Vial

Pre-Filled Syringe

Streptococcus Pneumoniae Polysaccharide Vaccine Segment by Application

Hospital

Clinic

Streptococcus Pneumoniae Polysaccharide Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Streptococcus Pneumoniae Polysaccharide Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Streptococcus Pneumoniae Polysaccharide Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Streptococcus Pneumoniae Polysaccharide Vaccine significant trends, drivers, influence factors in global and regions.

6. To analyze Streptococcus Pneumoniae Polysaccharide Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Streptococcus Pneumoniae Polysaccharide Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Streptococcus Pneumoniae Polysaccharide Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Streptococcus Pneumoniae Polysaccharide Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Streptococcus Pneumoniae Polysaccharide Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Streptococcus Pneumoniae Polysaccharide Vaccine industry.

Chapter 3: Detailed analysis of Streptococcus Pneumoniae Polysaccharide Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Streptococcus Pneumoniae Polysaccharide Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Streptococcus Pneumoniae Polysaccharide Vaccine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Streptococcus Pneumoniae Polysaccharide Vaccine Industry Trends Table 2. Streptococcus Pneumoniae Polysaccharide Vaccine Industry Drivers Table 3. Streptococcus Pneumoniae Polysaccharide Vaccine Industry Opportunities and Challenges Table 4. Streptococcus Pneumoniae Polysaccharide Vaccine Industry Restraints Table 5. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Share by Company (2021-2026) Table 7. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Volume Share by Company (2021-2026) Table 9. Global Streptococcus Pneumoniae Polysaccharide Vaccine Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Streptococcus Pneumoniae Polysaccharide Vaccine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Streptococcus Pneumoniae Polysaccharide Vaccine Key Company Manufacturing Base & Headquarters Table 12. Global Streptococcus Pneumoniae Polysaccharide Vaccine Company, Product Type & Application Table 13. Global Streptococcus Pneumoniae Polysaccharide Vaccine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Streptococcus Pneumoniae Polysaccharide Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Single Dose Vial Table 18. Significant Companies of Pre-Filled Syringe Table 19. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Volume Share by Type (2021-2026) Table 23. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Volume Share by Type (2027-2032) Table 24. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type (2021-2026) Table 28. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Volume by Application (2021-2026) & (K Units) Table 33. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Volume by Application (2027-2032) & (K Units) Table 34. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Volume Share by Application (2021-2026) Table 35. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Volume Share by Application (2027-2032) Table 36. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application (2021-2026) Table 40. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application (2027-2032) Table 41. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Region (2021-2026) & (K Units) Table 43. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Region (2021-2026) Table 44. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Region (2027-2032) & (K Units) Table 45. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Region (2027-2032) Table 46. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Region (2021-2026) Table 49. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Region (2027-2032) Table 51. Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2021-2026) & (K Units) Table 56. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Country (2021-2026) Table 57. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2027-2032) & (K Units) Table 58. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Country (2027-2032) Table 59. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Market Share by Country (2021-2026) Table 61. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Market Share by Country (2027-2032) Table 63. Yuxi Watson Biotechnology Co., Ltd Company Information Table 64. Yuxi Watson Biotechnology Co., Ltd Business Overview Table 65. Yuxi Watson Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Yuxi Watson Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 67. Yuxi Watson Biotechnology Co., Ltd Recent Development Table 68. Merck & Co.,Inc Company Information Table 69. Merck & Co.,Inc Business Overview Table 70. Merck & Co.,Inc Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Merck & Co.,Inc Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 72. Merck & Co.,Inc Recent Development Table 73. Pfizer Inc Company Information Table 74. Pfizer Inc Business Overview Table 75. Pfizer Inc Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Pfizer Inc Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 77. Pfizer Inc Recent Development Table 78. Chengdu Institute of Biological Products Co., Ltd Company Information Table 79. Chengdu Institute of Biological Products Co., Ltd Business Overview Table 80. Chengdu Institute of Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Chengdu Institute of Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 82. Chengdu Institute of Biological Products Co., Ltd Recent Development Table 83. Beijing Minhai Biotechnology Co., Ltd Company Information Table 84. Beijing Minhai Biotechnology Co., Ltd Business Overview Table 85. Beijing Minhai Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Beijing Minhai Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 87. Beijing Minhai Biotechnology Co., Ltd Recent Development Table 88. Beijing Kexing Biological Products Co., Ltd Company Information Table 89. Beijing Kexing Biological Products Co., Ltd Business Overview Table 90. Beijing Kexing Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Beijing Kexing Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 92. Beijing Kexing Biological Products Co., Ltd Recent Development Table 93. Serum Institute of India Pvt. Ltd Company Information Table 94. Serum Institute of India Pvt. Ltd Business Overview Table 95. Serum Institute of India Pvt. Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Serum Institute of India Pvt. Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 97. Serum Institute of India Pvt. Ltd Recent Development Table 98. Sanofi Pasteur Company Information Table 99. Sanofi Pasteur Business Overview Table 100. Sanofi Pasteur Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Sanofi Pasteur Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 102. Sanofi Pasteur Recent Development Table 103. Glaxosmithkline Plc Company Information Table 104. Glaxosmithkline Plc Business Overview Table 105. Glaxosmithkline Plc Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Glaxosmithkline Plc Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 107. Glaxosmithkline Plc Recent Development Table 108. China National Biotec Group Company Information Table 109. China National Biotec Group Business Overview Table 110. China National Biotec Group Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. China National Biotec Group Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 112. China National Biotec Group Recent Development Table 113. Astellas Pharma Inc Company Information Table 114. Astellas Pharma Inc Business Overview Table 115. Astellas Pharma Inc Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Astellas Pharma Inc Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 117. Astellas Pharma Inc Recent Development Table 118. Key Raw Materials Table 119. Raw Materials Key Suppliers Table 120. Streptococcus Pneumoniae Polysaccharide Vaccine Distributors List Table 121. Streptococcus Pneumoniae Polysaccharide Vaccine Customers List Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Streptococcus Pneumoniae Polysaccharide Vaccine Product Image Figure 2. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales (2021-2032) & (K Units) Figure 5. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Streptococcus Pneumoniae Polysaccharide Vaccine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Single Dose Vial Image Figure 10. Pre-Filled Syringe Image Figure 11. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Volume Share by Type (2021-2032) Figure 14. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Volume Share by Application (2021-2032) Figure 22. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application (2021-2032) Figure 25. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 26. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value (2021-2032) & (US$ Million) Figure 30. North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value (2021-2032) & (US$ Million) Figure 36. South America Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Streptococcus Pneumoniae Polysaccharide Vaccine Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Streptococcus Pneumoniae Polysaccharide Vaccine Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Single Dose Vial
  • Pre-Filled Syringe
Applications
  • Hospital
  • Clinic
Companies covered
  • Yuxi Watson Biotechnology Co., Ltd
  • Merck & Co.,Inc
  • Pfizer Inc
  • Chengdu Institute of Biological Products Co., Ltd
  • Beijing Minhai Biotechnology Co., Ltd
  • Beijing Kexing Biological Products Co., Ltd
  • Serum Institute of India Pvt. Ltd
  • Sanofi Pasteur
  • Glaxosmithkline Plc
  • China National Biotec Group
  • Astellas Pharma Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value (2021-2032)
  4. 1.2.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Volume (2021-2032)
  5. 1.2.3 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Streptococcus Pneumoniae Polysaccharide Vaccine Market Dynamics
  1. 2.1 Streptococcus Pneumoniae Polysaccharide Vaccine Industry Trends
  2. 2.2 Streptococcus Pneumoniae Polysaccharide Vaccine Industry Drivers
  3. 2.3 Streptococcus Pneumoniae Polysaccharide Vaccine Industry Opportunities and Challenges
  4. 2.4 Streptococcus Pneumoniae Polysaccharide Vaccine Industry Restraints
3 Streptococcus Pneumoniae Polysaccharide Vaccine Market by Company
  1. 3.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Company Revenue Ranking in 2025
  2. 3.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Company (2021-2026)
  3. 3.3 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Volume by Company (2021-2026)
  4. 3.4 Global Streptococcus Pneumoniae Polysaccharide Vaccine Average Price by Company (2021-2026)
  5. 3.5 Global Streptococcus Pneumoniae Polysaccharide Vaccine Company Ranking (2024-2026)
  6. 3.6 Global Streptococcus Pneumoniae Polysaccharide Vaccine Company Manufacturing Base and Headquarters
  7. 3.7 Global Streptococcus Pneumoniae Polysaccharide Vaccine Company Product Type and Application
  8. 3.8 Global Streptococcus Pneumoniae Polysaccharide Vaccine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Streptococcus Pneumoniae Polysaccharide Vaccine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Streptococcus Pneumoniae Polysaccharide Vaccine Market by Type
  1. 4.1 Streptococcus Pneumoniae Polysaccharide Vaccine Type Introduction
  2. 4.1.1 Single Dose Vial
  3. 4.1.2 Pre-Filled Syringe
  4. 4.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Volume by Type
  5. 4.2.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value by Type
  9. 4.3.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value by Type (2021-2032)
  11. 4.3.3 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type (2021-2032)
5 Streptococcus Pneumoniae Polysaccharide Vaccine Market by Application
  1. 5.1 Streptococcus Pneumoniae Polysaccharide Vaccine Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Volume by Application
  5. 5.2.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value by Application
  9. 5.3.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value by Application (2021-2032)
  11. 5.3.3 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application (2021-2032)
6 Streptococcus Pneumoniae Polysaccharide Vaccine Regional Sales and Value Analysis
  1. 6.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Region: 2021-2026
  4. 6.2.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Region (2027-2032)
  5. 6.3 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value by Region (2027-2032)
  9. 6.5 Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value (2021-2032)
  12. 6.6.2 North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value (2021-2032)
  15. 6.7.2 Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value (2021-2032)
  21. 6.9.2 South America Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Country, 2025 VS 2032
7 Streptococcus Pneumoniae Polysaccharide Vaccine Country-level Sales and Value Analysis
  1. 7.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2021-2032)
  4. 7.3.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2021-2026)
  5. 7.3.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2027-2032)
  6. 7.4 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Streptococcus Pneumoniae Polysaccharide Vaccine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Yuxi Watson Biotechnology Co., Ltd
  2. 8.1.1 Yuxi Watson Biotechnology Co., Ltd Company Information
  3. 8.1.2 Yuxi Watson Biotechnology Co., Ltd Business Overview
  4. 8.1.3 Yuxi Watson Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Yuxi Watson Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  6. 8.1.5 Yuxi Watson Biotechnology Co., Ltd Recent Developments
  7. 8.2 Merck & Co.,Inc
  8. 8.2.1 Merck & Co.,Inc Company Information
  9. 8.2.2 Merck & Co.,Inc Business Overview
  10. 8.2.3 Merck & Co.,Inc Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Merck & Co.,Inc Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  12. 8.2.5 Merck & Co.,Inc Recent Developments
  13. 8.3 Pfizer Inc
  14. 8.3.1 Pfizer Inc Company Information
  15. 8.3.2 Pfizer Inc Business Overview
  16. 8.3.3 Pfizer Inc Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Inc Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  18. 8.3.5 Pfizer Inc Recent Developments
  19. 8.4 Chengdu Institute of Biological Products Co., Ltd
  20. 8.4.1 Chengdu Institute of Biological Products Co., Ltd Company Information
  21. 8.4.2 Chengdu Institute of Biological Products Co., Ltd Business Overview
  22. 8.4.3 Chengdu Institute of Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Chengdu Institute of Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  24. 8.4.5 Chengdu Institute of Biological Products Co., Ltd Recent Developments
  25. 8.5 Beijing Minhai Biotechnology Co., Ltd
  26. 8.5.1 Beijing Minhai Biotechnology Co., Ltd Company Information
  27. 8.5.2 Beijing Minhai Biotechnology Co., Ltd Business Overview
  28. 8.5.3 Beijing Minhai Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Beijing Minhai Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  30. 8.5.5 Beijing Minhai Biotechnology Co., Ltd Recent Developments
  31. 8.6 Beijing Kexing Biological Products Co., Ltd
  32. 8.6.1 Beijing Kexing Biological Products Co., Ltd Company Information
  33. 8.6.2 Beijing Kexing Biological Products Co., Ltd Business Overview
  34. 8.6.3 Beijing Kexing Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Beijing Kexing Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  36. 8.6.5 Beijing Kexing Biological Products Co., Ltd Recent Developments
  37. 8.7 Serum Institute of India Pvt. Ltd
  38. 8.7.1 Serum Institute of India Pvt. Ltd Company Information
  39. 8.7.2 Serum Institute of India Pvt. Ltd Business Overview
  40. 8.7.3 Serum Institute of India Pvt. Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Serum Institute of India Pvt. Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  42. 8.7.5 Serum Institute of India Pvt. Ltd Recent Developments
  43. 8.8 Sanofi Pasteur
  44. 8.8.1 Sanofi Pasteur Company Information
  45. 8.8.2 Sanofi Pasteur Business Overview
  46. 8.8.3 Sanofi Pasteur Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Sanofi Pasteur Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  48. 8.8.5 Sanofi Pasteur Recent Developments
  49. 8.9 Glaxosmithkline Plc
  50. 8.9.1 Glaxosmithkline Plc Company Information
  51. 8.9.2 Glaxosmithkline Plc Business Overview
  52. 8.9.3 Glaxosmithkline Plc Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Glaxosmithkline Plc Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  54. 8.9.5 Glaxosmithkline Plc Recent Developments
  55. 8.10 China National Biotec Group
  56. 8.10.1 China National Biotec Group Company Information
  57. 8.10.2 China National Biotec Group Business Overview
  58. 8.10.3 China National Biotec Group Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 China National Biotec Group Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  60. 8.10.5 China National Biotec Group Recent Developments
  61. 8.11 Astellas Pharma Inc
  62. 8.11.1 Astellas Pharma Inc Company Information
  63. 8.11.2 Astellas Pharma Inc Business Overview
  64. 8.11.3 Astellas Pharma Inc Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Astellas Pharma Inc Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  66. 8.11.5 Astellas Pharma Inc Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Streptococcus Pneumoniae Polysaccharide Vaccine Value Chain Analysis
  2. 9.1.1 Streptococcus Pneumoniae Polysaccharide Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Streptococcus Pneumoniae Polysaccharide Vaccine Sales Mode & Process
  6. 9.2 Streptococcus Pneumoniae Polysaccharide Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Streptococcus Pneumoniae Polysaccharide Vaccine Distributors
  9. 9.2.3 Streptococcus Pneumoniae Polysaccharide Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst